Firstly, QB1561 exhibited remarkable potency in suppressing the proliferation of cancer cells overexpressing ABC transporters, outperforming both the parent drug AF and certain clinically utilized chemotherapeutics that are substrates of ABCB1 or ABCG2. The gene discussed is ABCG2; the disease is cancer.